Trial Profile
A Prospective, Multi-center, Single Armed Registry to Evaluate The Safety and Efficacy of 'AVI' Stent for Treating Coronary Revascularization
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 Apr 2021
Price :
$35
*
At a glance
- Drugs Arsenic trioxide (Primary)
- Indications Coronary artery restenosis; Coronary disorders; Ischaemic heart disorders; Myocardial ischaemia
- Focus Adverse reactions
- Acronyms PERFECT-I
- Sponsors Beijing AmsinoMed Medical Device Co
- 24 Jun 2017 Planned End Date changed from 1 Jun 2020 to 1 Apr 2021.
- 19 Jun 2014 New trial record